Regulations Needed to Improve Clinical Adoption Of CBD as Medicine
There must be clear rules and regulations in effect if we are to see medical-grade CBD become widely accepted amongst clinicians.
One preliminary study suggests CBD may help to fight Covid-19
Further studies will be required to verify the research and facilitate the creation of CBD-centric solutions suitable for Covid-19 patients.
presented by
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
GW Pharmaceuticals’ cannabis-derived epilepsy drug wins European approval
The European Commission approved GW Pharma's Epidyolex as a treatment for seizures in two rare and severe forms of epilepsy. The drug won FDA approval last year.
Sandoz gets into the weeds with cannabis medical product manufacturer Tilray
The Canadian company's shares reached a high price after it signed a framework agreement with Novartis's generics arm that would enable global commercialization.
GW Pharmaceuticals gets first FDA approval for CBD-based drug
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
5 companies mixing medicine and marijuana
From eye drops for glaucoma to chewing gum for irritable bowel syndrome, derivatives of cannabis are making their way into FDA trials in pursuit of a biotech/pharma market projected to reach $20 billion by 2020.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.